ClinicalTrials.Veeva

Menu

A Study of Vitamin D in Subjects With Alopecia Areata

A

Avera McKennan Hospital & University Health Center

Status

Completed

Conditions

Alopecia Areata

Study type

Observational

Funder types

Other

Identifiers

NCT01328678
ARI-1270-Alopecia

Details and patient eligibility

About

The objective of this study is to assess the parathyroid-vitamin D-calcium axis in subjects with alopecia areata. The hypothesis behind this study is that hypovitaminosis D might contribute to the pathogenesis of alopecia areata.

Full description

Alopecia Areata (AA) is a T-Cell mediated, non-scarring, polygenic, autoimmune disease of the hair follicle. It has been reported to be associated with other autoimmune diseases, especially autoimmune thyroid disease and vitiligo. It is more common in females. Recently, vitamin D deficiency has been claimed to contribute to the pathogenesis of multiple autoimmune disease. There is a strong inverse correlation between the level of 25-hydroxyvitamin D levels and the autoimmune disease in adolescents.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women who are at least 18 years old
  • Subjects with newly diagnosed with alopecia areata

Exclusion criteria

  • Subjects who take supplemental Vitamin D, by itself or as a part of a multivitamin

Trial design

10 participants in 1 patient group

Alopecia Areata
Description:
Individuals with Alopecia Areata (AA)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems